Form 4: Enovix Director Pegah Ebrahimi Receives RSU Grant

Director Pegah Ebrahimi was granted 29,104 restricted stock units as part of Enovix Corporation's equity compensation program.

Summary

• Director Pegah Ebrahimi acquired 29,104 restricted stock units (RSUs) on June 11, 2026.
• Each RSU represents a contingent right to receive one share of Enovix common stock.
• The grant increases the director's total beneficial ownership to 102,043 shares.
• The RSUs are subject to a vesting schedule spanning from September 2026 through June 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• The issuance of RSUs results in potential future dilution for existing shareholders.

Risks

• Vesting is contingent upon the director's continuous service to the company.

Future Outlook

The RSUs will vest in four equal quarterly installments, contingent upon the director's continued service, concluding by June 2027.

Management Comments

• The transaction reflects standard equity compensation for board members.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard practice in the technology and battery manufacturing sectors to ensure board alignment with corporate performance goals.

Comparison to Industry Standards

• The use of quarterly vesting schedules for director equity is consistent with standard corporate governance practices for NASDAQ-listed companies.

Stakeholder Impact

• Minor dilution impact on existing shareholders due to future share issuance upon RSU settlement.

Next Steps

• Vesting of RSU tranches beginning September 11, 2026.

Key Dates

Keywords

Enovix, ENVX, Form 4, Insider Transaction, Equity Compensation, Director Compensation